Related Experiment Video
Updated: Jun 22, 2025

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Prediction of Potential Risk for Flupyradifurone and Its Transformation Products to Hydrobionts
Chao Shen1,2, Xinglu Pan1, Xiaohu Wu1
1State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100193, P. R. China.
Abstract:
Flupyradifurone (FPF) is considered the latest generation of neonicotinoid insecticides. Here, we investigated the toxicity and ecological risk of FPF and its aerobic transformation products (TPs) to aquatic species using the method of prediction. We found that FPF exhibited moderate or high toxicity to some aquatic species. The 5% hazardous concentration of FPF was 3.84 μg/L for aquatic organisms. We obtained 91 aerobic TPs for FPF, and almost half of FPF TPs exhibited toxicity to fish or Daphnia. Eleven of the TPs of FPF exhibited a high or moderate risk to aquatic ecosystems. All FPF TPs with high and moderate risks contained a 6-chloropyridine ring structure, indicating that the derivant of a pyridine ring exhibits potential risks to aquatic ecosystems. Our results provide insight into the potential risk of FPF to aquatic ecosystems and could be used to help set criteria to control pollution caused by FPF.
More Related Videos
00:05In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
14:20High Throughput SiRNA Screening for Chloropicrin and Hydrogen Fluoride-Induced Cornea Epithelial Cell Injury
Published on: June 16, 2018
Related Concept Videos
Drug Biotransformation: Overview
Drug Metabolism: Phase II Reactions
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Phase II Reactions: Glucuronidation
Drug Distribution: Plasma Protein Binding